Since our data show that palmitoylation of GNA13 is required for its function in regulating the BCL2 expression, inhibiting GNA13 palmitoylation may sensitize the GCB-DLBCL cells with WT GNA13 to BCL2 inhibitors. Here, BCL2 is linked to diffuse large B-cell lymphoma.